Ascend Acquires Beacon Gene Therapy Manufacturing Site
Ascend Advanced Therapies, a gene therapy development partner, has purchased Beacon Therapeutics’ contract, manufacturing, and controls team—along with the company's site, previously owned by UF Innovate | Accelerate graduate AGTC, located in Alachua, FL—a town considered to be a “biotech hub” in the state. The acquisition introduces a good manufacturing practice (GMP) plant into the fold, along with process and analytical development capabilities.
First Case of Accelerated Healing of a Recalcitrant Diabetic Ulcer Using Purified Amniotic Fluid
Neobiosis LLC, a client of UF Innovate | Accelerate @Sid Martin Biotech, recently presented the first case of accelerated healing of a diabetic ulcer using purified amniotic fluid. This research poses the use of this fluid as a possible treatment method for diabetic foot ulcers, one of the most painful complications of diabetes, and a difficult one to treat.
Entrinsic Bioscience Announces Breakthrough Innovation for Next Generation Sports and Recreational Rehydration™ Beverages
Entrinsic Bioscience has published a ground-breaking clinical study demonstrating the potential for next-generation sports and rehydration beverages, powered by its new Ultra-Hydrating HeatDefense™ formula which promotes dual action rapid rehydration with new levels of heat protection during sports, physical exertion and high heat stress.
BioMérieux Receives CE Mark for Biomarker Assay for Mild TBI
BioMérieux, which signed an agreement in 2017 with Banyan Biomarkers to commercialize its TBI assay, has obtained the CE Mark for its assay to detect two biomarkers associated with mild traumatic brain injury (mTBI).
Project NextGen Selects Initial Vaccine Candidates and Awards Over $500 Million to Advance Development of Vaccines and Therapeutics
BARDA is awarding over $240 million to support Project NextGen clinical studies for COVID-19 vaccines, including investments in cold-chain sample management, genomic sequencing, and increased central laboratory capacity for sample testing.
UF Innovate | Accelerate client BioInfoExperts is among the recipients. BARDA provided $4 million to the startup to provide genomic sequencing of COVID-19.
Oragenics, Inc. Announces Private Placement
Oragenics, a UF startup, is partnering with healthcare investors. They've privately placed 404,728 shares of common stock and 404,728 shares of Series E Mirroring Preferred Stock to fight infectious diseases, including coronaviruses.
Hack #10 | Adaptive Pivots Can Help You Stay Ahead of the Curve
In today’s ever-changing business landscape, the ability to adapt and make strategic pivots is essential for long-term success. Businesses often face challenges such as dry spells, economic uncertainties, and market corrections that necessitate a shift in strategies and operations. Let’s explore three key areas where businesses can pivot to navigate obstacles and growth effectively to stay ahead of the curve.
Pheronym Lands $1 Million National Science Foundation Sbir Phase II Grant
UF Innovate | Accelerate alum, Pheronym, an ag-biotech pest management company, has been awarded a second non-dilutive National Science Foundation (NSF) SBIR Phase II for $1 Million. The grant will fund the final steps to scaling commercial manufacturing of their sustainable, eco-, and climate-friendly approach to pest control. The target pests include Thrips, a globally important pest that developed resistance to chemical pesticides.
Positive Results in Cancer Vaccine Trial for Merkel Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
Morphogenesis, Inc., a biotechnology company focused on developing cancer vaccines, in partnership with CohBar, believes they have met their milestone with IFx-HU2.0, a cancer vaccine studied in advanced Merkel cell carcinoma and squamous cell carcinoma.
Dmitry Rinberg on the Mysteries of Smell
"Don't miss this fascinating interview with Dmitry Rinberg, Co-founder and Chief Science Advisor of Canaery, a resident of UF Innovate | Accelerate, as he explores the mysteries of smell with Vasant Dhar. Join AI-pioneer Vasant Dhar as he hosts 'Brave New World' and discover the transformation of humanity by machines in the post-COVID era. The conversation will touch on various topics such as work, health, faith, emotional well-being, government, democracy, and freedom."
